ProfileGDS5678 / 1427973_s_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 57% 57% 57% 63% 57% 65% 56% 57% 57% 63% 57% 58% 57% 57% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.5027257
GSM967853U87-EV human glioblastoma xenograft - Control 23.4699857
GSM967854U87-EV human glioblastoma xenograft - Control 33.4733357
GSM967855U87-EV human glioblastoma xenograft - Control 43.7318163
GSM967856U87-EV human glioblastoma xenograft - Control 53.4173657
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.9297565
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.4955956
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.4522257
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.4274757
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.766263
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.4560457
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.4443858
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.4593657
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.4593457